Hence, although the decrease in MIF urinary excretion after the introduction of immunosuppressive therapy seems to be a good prognosis of favorable treatment outcome, it is not the case in all patients with GN, but only in participants with proliferative glomerulonephritis and in whom this reduction was statistically significant. Here, MIF is linked to proliferative glomerulonephritis.